Summit Global Investments Lowers Stake in HCA Healthcare, Inc. (NYSE:HCA)

Summit Global Investments lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 39.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,199 shares of the company’s stock after selling 2,126 shares during the quarter. Summit Global Investments’ holdings in HCA Healthcare were worth $1,028,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Atlantic Edge Private Wealth Management LLC bought a new stake in HCA Healthcare in the fourth quarter worth $27,000. Bangor Savings Bank increased its position in HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares during the last quarter. GPS Wealth Strategies Group LLC increased its position in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after acquiring an additional 71 shares during the last quarter. LifeSteps Financial Inc. purchased a new stake in shares of HCA Healthcare during the first quarter valued at $33,000. Finally, Rise Advisors LLC purchased a new stake in shares of HCA Healthcare during the first quarter valued at $36,000. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,844 shares of company stock valued at $3,185,932. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

HCA stock traded up $1.10 during midday trading on Tuesday, reaching $375.31. The stock had a trading volume of 678,943 shares, compared to its average volume of 1,141,645. The company’s fifty day simple moving average is $341.89 and its 200 day simple moving average is $329.44. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a market cap of $98.30 billion, a price-to-earnings ratio of 18.71, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $377.88.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the company posted $4.29 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 22.43 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Monday. Wells Fargo & Company increased their price target on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 30th. Robert W. Baird initiated coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price target for the company. Finally, Barclays increased their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $354.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.